KFS
Kurt F. Somerville Portfolio holdings
AUM
$594M
This Quarter Return
+10.87%
1 Year Return
+12.39%
3 Year Return
+68.79%
5 Year Return
+108.17%
10 Year Return
+271.21%
AUM
$585M
AUM Growth
+$585M
(+10%)
Cap. Flow
+$8.33M
Cap. Flow
% of AUM
1.42%
Top 10 Holdings %
Top 10 Hldgs %
41.22%
Holding
102
New
6
Increased
33
Reduced
34
Closed
3
Top Buys
| 1 |
Ball Corp
BALL
|
$3.21M |
| 2 |
Carrier Global
CARR
|
$2.88M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$1.1M |
| 4 |
UnitedHealth
UNH
|
$857K |
| 5 |
Aptiv
APTV
|
$855K |
Top Sells
| 1 |
Novartis
NVS
|
$4.1M |
| 2 |
CVS Health
CVS
|
$1.94M |
| 3 |
Advanced Micro Devices
AMD
|
$1.36M |
| 4 |
NVIDIA
NVDA
|
$616K |
| 5 |
iShares Core S&P 500 ETF
IVV
|
$566K |
Sector Composition
| 1 | Technology | 30.87% |
| 2 | Healthcare | 21.23% |
| 3 | Industrials | 12.78% |
| 4 | Consumer Discretionary | 11.44% |
| 5 | Financials | 5.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Amgen
AMGN
$155B
| $342K | 0.06% |
1,202
| – | – |
|
77
Pfizer
PFE
$142B
| $339K | 0.06% |
12,233
-1,558
| -11% | -$43.2K |
|
78
TotalEnergies
TTE
$137B
| $337K | 0.06% |
4,900
| – | – |
|
79
Illumina
ILMN
$15.8B
| $334K | 0.06% |
2,435
-1,660
| -41% | -$228K |
|
80
Bristol-Myers Squibb
BMY
$96B
| $326K | 0.06% |
6,007
-1,275
| -18% | -$69.1K |
|
81
Waste Management
WM
$90.9B
| $311K | 0.05% |
1,460
-160
| -10% | -$34.1K |
|
82
Texas Pacific Land
TPL
$21.5B
| $304K | 0.05% |
525
+350
| +200% | +$202K |
|
83
Gilead Sciences
GILD
$140B
| $279K | 0.05% |
3,805
| – | – |
|
84
Pinterest
PINS
$25B
| $273K | 0.05% |
7,870
| – | – |
|
85
Oracle
ORCL
$633B
| $269K | 0.05% |
2,143
-205
| -9% | -$25.8K |
|
86
NXP Semiconductors
NXPI
$59.2B
| $266K | 0.05% |
1,075
| – | – |
|
87
SPDR S&P 500 ETF Trust
SPY
$653B
| $254K | 0.04% |
+486
| New | +$254K |
|
88
Meta Platforms (Facebook)
META
$1.85T
| $243K | 0.04% |
+500
| New | +$243K |
|
89
Dover
DOV
$24.5B
| $230K | 0.04% |
+1,300
| New | +$230K |
|
90
T Rowe Price
TROW
$23.6B
| $219K | 0.04% |
+1,800
| New | +$219K |
|
91
Kimberly-Clark
KMB
$42.7B
| $213K | 0.04% |
1,650
| – | – |
|
92
Edwards Lifesciences
EW
$47.8B
| – | – |
-4,600
| Closed | -$351K |
|
93
Veralto
VLTO
$26.4B
| – | – |
-3,221
| Closed | -$265K |
|